Within-class differences in cancer risk for sulfonylurea treatments in patients with type 2 diabetes (ZODIAC-55) – a study protocol

被引：0
|
作者：
Dennis Schrijnders
Geertruida H. de Bock
Sebastiaan T. Houweling
Kornelis J. J. van Hateren
Klaas H. Groenier
Jeffrey A. Johnson
Henk J. G. Bilo
Nanne Kleefstra
Gijs W. D. Landman
机构：
[1] Isala,Diabetes Centre
[2] Langerhans Medical Research Group,Department of Epidemiology
[3] University of Groningen,Department of General Practice
[4] University Medical Center Groningen,Department of Internal Medicine
[5] University of Groningen,Department of Internal Medicine
[6] University Medical Center Groningen,Department of Internal Medicine
[7] School of Public Health,undefined
[8] University of Alberta,undefined
[9] University of Groningen,undefined
[10] University Medical Center Groningen,undefined
[11] Isala,undefined
[12] Gelre Hospital,undefined
来源：
BMC Cancer | / 17卷
关键词：
Type 2 diabetes; Sulfonylureas; Cancer; Within-class differences;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Metformin reduces the risk of cancer in patients with type 2 diabetes An analysis based on the Korean National Diabetes Program Cohort
    Kim, Hae Jin
    Lee, SooJin
    Chun, Ki Hong
    Jeon, Ja Young
    Han, Seung Jin
    Kim, Dae Jung
    Kim, Young Seol
    Woo, Jeong-Taek
    Nam, Moon-Suk
    Baik, Sei Hyun
    Ahn, Kyu Jeung
    Lee, Kwan Woo
    MEDICINE, 2018, 97 (08)
  • [32] Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study
    Faillie, Jean-Luc
    Azoulay, Laurent
    Patenaude, Valerie
    Hillaire-Buys, Dominique
    Suissa, Samy
    BMJ-BRITISH MEDICAL JOURNAL, 2014, 348
  • [33] Insulin glargine use and cancer risk among patients with type 2 diabetes mellitus: a real-world study in Shanghai, China
    Qi, Jiying
    He, Ping
    Yao, Huayan
    Sun, Wen
    Lu, Ping
    Zhang, Zizheng
    Cui, Bin
    Ning, Guang
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2024, 44 (01) : 137 - 144
  • [34] Insulin glargine use and cancer risk among patients with type 2 diabetes mellitus: a real-world study in Shanghai, China
    Jiying Qi
    Ping He
    Huayan Yao
    Wen Sun
    Ping Lu
    Zizheng Zhang
    Bin Cui
    Guang Ning
    International Journal of Diabetes in Developing Countries, 2024, 44 : 137 - 144
  • [35] Differences in risk factors of malignancy between men and women with type 2 diabetes: A retrospective case-control study
    Dabrowski, Mariusz
    Szymanska-Garbacz, Elektra
    Miszczyszyn, Zofia
    Derezinski, Tadeusz
    Czupryniak, Leszek
    ONCOTARGET, 2017, 8 (40) : 66940 - 66950
  • [36] Increased Risk of Site-Specific Cancer in People with Type 2 Diabetes: A National Cohort Study
    Linkeviciute-Ulinskiene, Donata
    Patasius, Ausvydas
    Zabuliene, Lina
    Stukas, Rimantas
    Smailyte, Giedre
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (01)
  • [37] Incidence and Mortality Risks of Cancer in Patients with Type 2 Diabetes: A Retrospective Study in Shanghai, China
    Gu, Yunjuan
    Hou, Xuhong
    Zheng, Ying
    Wang, Chunfang
    Zhang, Lei
    Li, Jie
    Huang, Zhezhou
    Han, Ming
    Bao, Yuqian
    Zhong, Weijian
    Jia, Weiping
    Cui, Shiwei
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2016, 13 (06)
  • [38] Efficacy and Safety of Lixisenatide in Japanese Patients with Type 2 Diabetes Insufficiently Controlled with Basal Insulin±Sulfonylurea: A Subanalysis of the GetGoal-L-Asia Study
    Seino, Y.
    Ikeda, Y.
    Niemoeller, E.
    Watanabe, D.
    Takagi, H.
    Yabe, D.
    Inagaki, N.
    HORMONE AND METABOLIC RESEARCH, 2015, 47 (12) : 895 - 900
  • [39] Association between uric acid, cancer incidence and mortality in patients with type 2 diabetes: Shanghai diabetes registry study
    Deng, Zixuan
    Gu, Yunjuan
    Hou, Xuhong
    Zhang, Lei
    Bao, Yuqian
    Hu, Cheng
    Jia, Weiping
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2016, 32 (03) : 325 - 332
  • [40] DPP4i, thiazolidinediones, or insulin and risks of cancer in patients with type 2 diabetes mellitus on metformin-sulfonylurea dual therapy with inadequate control
    Wong, Carlos K. H.
    Man, Kenneth K. C.
    Chan, Esther W. Y.
    Wu, Tingting
    Tse, Emily T. Y.
    Wong, Ian C. K.
    Lam, Cindy L. K.
    BMJ OPEN DIABETES RESEARCH & CARE, 2020, 8 (01)
12345